T-cells in breast cancer were extensively characterised with a meta-analysis of over 12,000 breast tumours demonstrating high levels of CD8, where T-cells were associated with improved BCSS in TNBC, HER2+ and ER+/HER2+ tumours but not ER+ HER2− [23]. This evidence concerns the gene CD8A and breast neoplasm.